| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.01B | +7.6% |
| Cost of Revenue | $342.3M | +5.0% |
| R&D Expense | $270.2M | +5.6% |
| SG&A Expense | $110.4M | +1.4% |
| Operating Income | $133.6M | +23.1% |
| Pre-tax Income | $166.6M | +17.5% |
| Income Tax | $37.6M | +95.0% |
| Net Income | $131.6M | +7.4% |
| EPS (Basic) | $2.66 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $960.6M | -21.3% |
| Accounts Receivable | $141.9M | +12.5% |
| Inventory | $94.4M | +8.0% |
| Current Assets | $1.27B | -14.1% |
| Total Assets | $2.14B | +4.8% |
| Current Liabilities | $663.1M | +251.2% |
| Total Liabilities | $1.25B | -1.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $153.3M | -25.7% |
| Capital Expenditures | $16.3M | +60.7% |
| Investing Cash Flow | -$358.5M | -1352.5% |
| Financing Cash Flow | -$55.0M | -115.9% |
| Free Cash Flow | $137.0M | -30.2% |
| +6.4% |
| EPS (Diluted) | $2.46 | +7.4% |
| Stockholders' Equity |
| $848.2M |
| +16.7% |